Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia
Abstract Background Tumour dormancy, a resistance mechanism employed by cancer cells, is a significant challenge in cancer treatment, contributing to minimal residual disease (MRD) and potential relapse. Despite its clinical importance, the mechanisms underlying tumour dormancy and MRD remain unclea...
Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
BMC
2024-09-01
|
Col·lecció: | Biological Research |
Matèries: | |
Accés en línia: | https://doi.org/10.1186/s40659-024-00540-y |